BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35790560)

  • 1. Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
    Escudero-Vilaplana V; Collado-Borrell R; Gómez Martínez-Sagrera P; Villanueva-Bueno C; Revuelta-Herrero JL; Gonzalez-Haba E; Hoyo-Muñoz Á; Jerez Gilarranz Y; Marzal-Alfaro B; Herranz A; Martin M; Sanjurjo M
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2855-2882. PubMed ID: 35790560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?
    McLay JS; Stewart D; George J; Rore C; Heys SD
    Eur J Clin Pharmacol; 2012 May; 68(5):811-9. PubMed ID: 22166933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use in breast cancer patients in Europe.
    Molassiotis A; Scott JA; Kearney N; Pud D; Magri M; Selvekerova S; Bruyns I; Fernadez-Ortega P; Panteli V; Margulies A; Gudmundsdottir G; Milovics L; Ozden G; Platin N; Patiraki E
    Support Care Cancer; 2006 Mar; 14(3):260-7. PubMed ID: 16143871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Huebner J
    J Cancer Res Clin Oncol; 2022 May; 148(5):1123-1135. PubMed ID: 34228225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk evaluation of the use of complementary and alternative medicines in cancer.
    Renet S; de Chevigny A; Hoacoglu S; Belkarfa AL; Jardin-Szucs M; Bezie Y; Jouveshomme S
    Ann Pharm Fr; 2021 Jan; 79(1):44-52. PubMed ID: 32485144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.
    Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E
    BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study.
    Zulkipli AF; Islam T; Mohd Taib NA; Dahlui M; Bhoo-Pathy N; Al-Sadat N; Abdul Majid H; Hussain S;
    Integr Cancer Ther; 2018 Jun; 17(2):312-321. PubMed ID: 29218996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of complementary and alternative medicine use among Tunisian cancer patients.
    Toukabri I; Said AB; Hamdi A; Mokrani A; Gabsi A; Ayed WB; Tounsi K; Limayem I
    J Oncol Pharm Pract; 2021 Dec; 27(8):1948-1957. PubMed ID: 33323022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
    Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
    J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE AMONG FAMILY MEDICINE PATIENTS--EXAMPLE OF THE TOWN OF ČAKOVEC].
    Vitale K; Munđar R; Sović S; Bergman-Marković B; Janev Holcer N
    Acta Med Croatica; 2014 Dec; 68(4-5):345-51. PubMed ID: 26285467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
    Hyodo I; Amano N; Eguchi K; Narabayashi M; Imanishi J; Hirai M; Nakano T; Takashima S
    J Clin Oncol; 2005 Apr; 23(12):2645-54. PubMed ID: 15728227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions from complementary and alternative medicine in patients with melanoma.
    Loquai C; Schmidtmann I; Garzarolli M; Kaatz M; Kähler KC; Kurschat P; Meiss F; Micke O; Muecke R; Muenstedt K; Nashan D; Stein A; Stoll C; Dechent D; Huebner J
    Melanoma Res; 2017 Jun; 27(3):238-242. PubMed ID: 28252553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary/alternative therapies by women with advanced-stage breast cancer.
    Shen J; Andersen R; Albert PS; Wenger N; Glaspy J; Cole M; Shekelle P
    BMC Complement Altern Med; 2002 Aug; 2():8. PubMed ID: 12175424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive approach to complementary and alternative medicine usage among patients from a vascular department.
    Cuen-Ojeda C; Hinojosa CA; Contreras-Yáñez I; Elenes-Sánchez E; Rosas-Ríos C; Méndez-Sosa MA; Ballinas-Sánchez A; Pascual-Ramos V
    Vascular; 2022 Apr; 30(2):310-319. PubMed ID: 33853457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
    Fremd C; Hack CC; Schneeweiss A; Rauch G; Wallwiener D; Brucker SY; Taran FA; Hartkopf A; Overkamp F; Tesch H; Fehm T; Hadji P; Janni W; Lüftner D; Lux MP; Müller V; Ettl J; Belleville E; Sohn C; Schuetz F; Beckmann MM; Fasching PA; Wallwiener M
    Arch Gynecol Obstet; 2017 May; 295(5):1239-1245. PubMed ID: 28331996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional Assessment and Use of Complementary and Alternative Medicine in Cancer Patients Treated With Radiotherapy and Chemotherapy.
    Güneş Bayır A; Guney M
    Altern Ther Health Med; 2019 Nov; 25(6):28-33. PubMed ID: 31221938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey.
    Irmak Z; Tanrıverdi Ö; Ödemiş H; Uysal DD
    Complement Ther Med; 2019 Jun; 44():143-150. PubMed ID: 31126547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.